Found 534 hits.
| 286 | Irani, C., Hallit, S.+, Weller, K., Maurer, M. El Haber, C., and Salameh, P.: Chronic urticaria in most patients is poorly controlled: Results of the development, validation, and real life application of the Arabic urticaria control test. Saudi Med. J. 2017: 38; 179-185. IF: 1.05 |
| 241 | Magerl, M., Altrichter, S., Borzova, E., Giménez-Arnau, A., Grattan, C. E. H., Lawlor, F., Mathelier-Fusade, P., Meshkova, R. Y., Zuberbier, T., Metz, M., and Maurer, M.+: The definition, diagnostic testing and management of chronic inducible urticarias –The EAACI/GA²LEN/EDF/UNEV 2016 consensus panel recommendations 2016 update and revision. Allergy 2016: 71; 780-802. IF: 7.36 |
| 263 | Longhurst, H. J.+, Zanichelli, A., Caballero, T., Bouillet, L., Aberer, W., Maurer, M. Fain, O., Fabien, V., and Andresen, I.: Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the icatibant outcome survey. Clin. Exp. Immunol. 2017: 188; 148-153. IF: 3.54 |
| 10. | Maurer, M., and Metz, M.: The status quo and quo vadis of mast cells. Exp. Dermatol. 2005: 14; 923-929. IF: 2.09 |
| 162. | Altrichter, S., Fok, J. S., Jiao, Q., Kolkhir, P., Pyatilova, P., Moñino-Romero, S., Scheffel, J., Siebenhaar, F., Steinert, C., Terhorst-Molawi, D., Xiang, Y.-K., Church, M. K., and Maurer, M.: Total IgE as marker in chronic spontaneous urticaria. Allergy Asthma Immunol. Res. 2021: 13; 206-218. IF: 5.1 |
r.162
| 129. | Maurer, M., Metz, M., Brehler, R., Hillen, U., Jakob, T., Mahler, V., Pföhler, C., Staubach, P., Treudler, R., Wedi, B., and Magerl, M.: Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence. J. Allergy Clin. Immunol. 2018: 141; 638-649. IF: 14.11 |
r.129
| 342 | Kolkhir, P.*, Grakhova, M.*, Bonnekoh, H., Krause, K.*, and Maurer, M.*+: Treatment of urticarial vasculitis: a systematic review. J. Allergy Clin. Immunol. 2019: 143; 458-466. IF: TBD (IF 2018: 14.11) |
| 280 | Asady, A., Ruft, J., Ellrich, A., Hawro, T., Maurer, M.+, and Altrichter, S.: Cholinergic urticaria patients of different age groups have distinct features. Clin. Exp. Allergy 2017: 47; 1609-1614. IF: 5.16 |
| 222 | Schubert, N., Dudeck, J., Liu, P., Karutz, A., Speier, S., Maurer, M. Tuckermann, J., and Dudeck, A.+: Mast cell promotion of T cell-driven antigen-induced arthritis despite being dispensable for antibody-induced arthritis in which T cells are bypassed. Arthritis Rheumatol. 2015: 67; 903-913. IF: 6.00 |
| 70 | Siebenhaar, F., Degener, F., Zuberbier, T., Martus, P., and Maurer, M.+: High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J. Allergy Clin. Immunol. 2009: 123; 672-679. IF: 9.16 |